Navigation Links
GenVec Reports Third Quarter 2009 Financial Results
Date:11/5/2009

$(3,562) $(6,839) $(14,052) $(19,649) ======= ======= ======== ======== Basic and diluted loss per share $(0.04) $(0.08) $(0.15) $(0.24) ====== ====== ====== ====== Shares used in computing basic and diluted net loss per share 101,001 88,422 93,953 80,884 ======= ====== ====== ======

                                      GenVec, Inc.
                            Selected Balance Sheet Information
                                     (in thousands)

                                              September 30, December 31,
                                                      2009         2008
                                                      ----         ----
                                                (Unaudited)

    Cash and investments                           $14,230      $17,357
    Working capital                                 10,753       11,728
    Total assets                                    16,513       22,767
    Stockholders' equity                            11,608       13,091

    Investor Contact:          Media Contact:
    GenVec, Inc.               Tiberend Strategic Advisors, Inc.
    Danielle M. DiPirro        Andrew Mielach
    (301) 944-1877             (212) 827-0020
    ddipirro@genvec.com        amielach@tiberendstrategicadvisors.com

SOURCE GenVec, Inc.


'/>"/>
SOURCE GenVec, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
2. GenVec Expands Contract Supporting Malaria Vaccine Program
3. GenVec Reports Second Quarter 2009 Financial Results
4. GenVec Receives an Approximately $2.5 Million Grant to Support Novel Cell Line Development
5. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
6. GenVec Announces Third Quarter 2009 Results Conference Call
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 27, 2015 Research ... of Jain PharmaBiotech,s new report "Cell Therapy ... offering. This report describes and evaluates ... started to play an important role in the ... replacing the old fashioned bone marrow transplants. Role ...
(Date:5/28/2015)... May 28, 2015 Natera, Inc., a ... study published in Ultrasound in Obstetrics & ... (SNP)-based non-invasive prenatal test (NIPT) can identify a ... A study based upon data collected ... occur in about 1 in 1,000 pregnancies, although ...
(Date:5/28/2015)... , May 28, 2015 RXi Pharmaceuticals Corporation ... discovering and developing innovative therapeutics, primarily in the areas ... a public offering of 26 million units at a ... gross proceeds of approximately $10.4 million. Each unit consists ... 13-month overallotment purchase right to purchase 0.50 of a ...
(Date:5/28/2015)... The Fertility Centers of New England is proud ... taken on a new and expanded role as Medical ... leadership, oversight and quality assurance for the practice. , ... team of experienced reproductive endocrinologists,” said Fertility Centers of ... “Her expertise and compassionate, individualized care have helped set ...
Breaking Biology Technology:Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 3RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director 2
... U.S. troops blew up enemy bridges with explosives in World ... forces. , In modern times, patrollers use explosives at ski ... when skiers arrive. , Other than creating the desired effect ... the microscopic details and extreme states of matter found within ...
... Stock Exchange Symbol: MS, EDMONTON, Dec. 11 ... developer in the treatment of multiple sclerosis (MS), ... (DSMB) has,reviewed data from the Company,s on-going MAESTRO-03 ... the treatment of secondary progressive MS and,recommended that ...
... Aids Mass Spectrometer Analysis -, HOPKINTON, Mass., ... CALP ) today announced the availability of the,Zephyr ... Solid,Phase Extraction (SPE). With features including a 96-well ... SPE Workstation is,designed to increase efficiency and streamline ...
Cached Biology Technology:Explosives at the microscopic scale produce shocking results 2BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction 2
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... already living in some humans that target and trap ... findings today at the 2005 American Society for Microbiology ... has its natural enemy, and HIV should not be ... the Department of Oral Biology, College of Dentistry, University ...
... A small trial testing the safety of an experimental ... the National Institutes of Health's (NIH) Clinical Center in ... in 15 healthy adult volunteers, was developed for human ... Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), ...
... essential to one of the plant kingdom's key immune ... a protective zone of dead cells around the infection ... how the plants keep from killing themselves after they ... Now, in the May 20 issue of the journal ...
Cached Biology News:Friendly bacteria in humans may protect against HIV 2NIAID begins clinical trial of West Nile virus vaccine 2NIAID begins clinical trial of West Nile virus vaccine 3Plant Sacrifices Cells to Fight Invaders 2
... Analyzer for superior sensitivity, mass accuracy, and resolving power., Specifications:, ... ion selection range: 150 - 4000 m/z, * Resolution: 14,000 (1400 ... * Dynamic range: 4 orders of magnitude ... ...
... M (OSM) is a pleiotropic cytokine produced ... sarcoma cells. OSM inhibits the growth of ... fibroblast, smooth muscle and Kaposis sarcoma cell ... low density lipoprotein receptor expression on hepatoma ...
... trinor Prostaglandin F2α isopropyl ester (15(R)-17-phenyl ... latanoprost-related isomer containing both a double ... (β) hydroxyl group at C-15. Similar ... ester is a potential impurity in ...
ACS Reagent Grade C 19 H 14 O 5 S Formula Weight: 354.38 PRODUCT SPECIFICATIONS Form: Rust/red crystalline powder Clarity of Solution: Passes test Visual Transition Interval: pH 6.8 - Yellow pH 8.2...
Biology Products: